All Pharma News
Beroni’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification

Beroni’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification
BIOSPACE
01 Jun 2022
Share Share
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors
GLOBENEWSWIRE
31 Mar 2022
Share Share
Beroni Group to Participate in the 2022 Virtual Growth Conference by Maxim Group

Beroni Group to Participate in the 2022 Virtual Growth Conference by Maxim Group
GLOBENEWSWIRE
23 Mar 2022
Share Share
Beroni Group sets up new R&D centre in China

Beroni Group sets up new R&D centre in China
BIOSPECTRUMASIA
03 Feb 2022
Share Share
Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China

Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China
GLOBENEWSWIRE
31 Jan 2022
Share Share
Drug developer Beroni Group files for a Nasdaq uplisting

Drug developer Beroni Group files for a Nasdaq uplisting
RENAISSANCECAPITAL
20 Dec 2021
Share Share
Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits

Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits
GLOBENEWSWIRE
18 Nov 2021
Share Share
Beroni Group Published an Article Related to Single-Domain Antibodies in FEBS

Beroni Group Published an Article Related to Single-Domain Antibodies in FEBS
GLOBENEWSWIRE
28 Oct 2021
Share Share
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Gov.PENAO

Beroni Group Received Approval for 43.5% R&D Rebate from Australian Gov.PENAO
YAHOO
09 Sep 2021
Share Share
Beroni Received Approval for 43.5% R&D Rebate from Australian Govt. for PENAO

Beroni Received Approval for 43.5% R&D Rebate from Australian Govt. for PENAO
GLOBENEWSWIRE
09 Sep 2021
Share Share